Research and clinical trials play a crucial role in enhancing the care and support provided to women during early pregnancy. By participating in these studies, we can improve outcomes and ensure that every woman receives the best possible care.
Explore ongoing research in early pregnancy.
The Amethyst Trial is currently finalising the protocol and document set ahead of sponsor Risk Assessment (approximately scheduled for May); after that they intend to proceed to full combined review by June/ July and will then be on track to begin opening sites to recruitment from the end of August.
The CERM trial is now closed and results will be published once available.
The GEM3 Trial results were published in the Lancet in 2023.
The Alife2 Trial results were published in The Lancet in 2023.
The MifeMiso Trial results were published in The Lancet in 2020.
The PRISM Trial results were published in the New England Journal of Medicine in 2019.
The TABLET Trial results were published in the New England Journal of Medicine in 2019.
The PROMISE Trial results were published in the New England Journal of Medicine in 2015.
The SIMPLANT Trial results were published in the Lancet in 2020.
Data collection completed 2024.
We are excited to open applications to join the AEPU Trainee Education Working Group.
Following the approval of our educational curriculum by the AEPU executive committee, we now anticipate this will form the basis of content development that will improve early pregnancy training for trainees and associated healthcare professionals. The deadline for applications is the 3rd April 2026.